© Reuters
Investing.com — Medtronic (NYSE:) has raised its annual revenue and earnings outlook following “broad-based, diversified” growth across several of the medical device manufacturer’s businesses in its fiscal second quarter.
This is a breaking story. Please check back later for updates.